{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:44:17Z","timestamp":1771472657183,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T00:00:00Z","timestamp":1467763200000},"content-version":"vor","delay-in-days":1374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.jtcvs.2012.07.001","type":"journal-article","created":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T12:03:38Z","timestamp":1345032218000},"page":"762-770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Thrombolysis in Myocardial Infarction (TIMI) Study Group experience"],"prefix":"10.1016","volume":"144","author":[{"given":"Eugene","family":"Braunwald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc S.","family":"Sabatine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2012.07.001_bib1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1152\/ajplegacy.1935.112.2.351","article-title":"The effect of coronary occlusion on myocardial contraction","volume":"112","author":"Tennant","year":"1935","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0002-8703(41)90415-5","article-title":"Experimental studies on the effect of temporary occlusion of coronary arteries. II. The production of myocardial infarction","volume":"22","author":"Blumgart","year":"1941","journal-title":"Am Heart J"},{"issue":"Suppl IV","key":"10.1016\/j.jtcvs.2012.07.001_bib3","first-page":"220","article-title":"Effect of drugs and of counterpulsation on myocardial oxygen consumption","volume":"40","author":"Braunwald","year":"1969","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/01.CIR.43.1.67","article-title":"Factors influencing infarct size following experimental coronary artery occlusion","volume":"43","author":"Maroko","year":"1971","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib5","doi-asserted-by":"crossref","first-page":"720","DOI":"10.7326\/0003-4819-79-5-720","article-title":"Modification of myocardial infarction size after coronary occlusion","volume":"79","author":"Maroko","year":"1973","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib6","first-page":"8","article-title":"Intracoronary administration of fibrinolysin in acute myocardial infarction","volume":"48","author":"Chazov","year":"1976","journal-title":"Ter Arkh"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJM198110013051401","article-title":"Myocardial salvage after intracoronary thrombolysis with streptokinase in acute myocardial infarction: assessment of intracoronary thallium-201","volume":"305","author":"Markis","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib8","doi-asserted-by":"crossref","unstructured":"The TIMI Study Group. Braunwald E (Chairman). The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med. 1985;312:932-6.","DOI":"10.1056\/NEJM198504043121437"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib9","doi-asserted-by":"crossref","unstructured":"The TIMI Study Group. Braunwald E (Chairman): Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial. N Engl J Med. 1989;320:618-27.","DOI":"10.1056\/NEJM198903093201002"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.CIR.83.2.422","article-title":"Immediate versus deferred \u03b2-blockade following thrombolytic therapy in patients with acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study","volume":"83","author":"Roberts","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0735-1097(02)01936-8","article-title":"Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation MI: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial","volume":"40","author":"Morrow","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib12","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa060898","article-title":"Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction","volume":"354","author":"Antman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib13","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation","volume":"352","author":"Sabatine","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1112277","article-title":"Rivaroxaban in patients with a recent acute coronary syndrome","volume":"366","author":"Mega","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib15","doi-asserted-by":"crossref","unstructured":"The TIMI III B Investigators. Braunwald E. (Chairman): Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-q-wave myocardial infarction. Results of the TIMI III B Trial. Circulation. 1994;89:1545-56.","DOI":"10.1161\/01.CIR.89.4.1545"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib16","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"344","author":"Cannon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib17","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/01.CIR.100.15.1593","article-title":"Enoxaparin prevents death and cardiac ischemic events in unstable angina\/non-Q-wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 11B Trial","volume":"100","author":"Antman","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib18","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib19","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(08)60422-5","volume":"371","author":"Wiviott","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib20","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.108.791061","volume":"118","author":"Wiviott","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib21","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.297.16.1775","article-title":"Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes. The MERLIN-TIMI 36 randomized trial","volume":"297","author":"Morrow","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib22","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/CIRCULATIONAHA.107.724880","volume":"116","author":"Scirica","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib23","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/CIRCULATIONAHA.107.763912","article-title":"Evaluation of glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial","volume":"119","author":"Morrow","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib24","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1056\/NEJMoa1200933","article-title":"Vorapaxar in the secondary prevention of atherothrombotic events","volume":"366","author":"Morrow","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib25","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib26","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.jacc.2005.03.077","article-title":"Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes. Results from the PROVE IT\u2013TIMI 22 trial","volume":"46","author":"Ray","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib27","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: a method for prognostication and therapeutic decision making","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib28","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/01.CIR.102.17.2031","article-title":"TIMI risk score for ST-elevation myocardial infarction. A convenient, bedside, clinical score for risk assessment at presentation. An Intravenous nPA for Treatment of infracting Myocardium Early II Trial substudy","volume":"102","author":"Morrow","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib29","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0140-6736(01)06649-1","article-title":"A simple risk index for rapid initial triage of patients with ST elevation myocardial infarction: An InTIME II Substudy","volume":"358","author":"Morrow","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib30","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/01.CIR.99.15.1945","article-title":"Relationship between TIMI frame count and clinical outcomes after thrombolytic administration","volume":"99","author":"Gibson","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1161\/01.CIR.101.2.125","article-title":"Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs","volume":"101","author":"Gibson","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib32","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199610313351802","article-title":"Cardiac-specific troponin I levels to predict the risk of mortality\u00a0in patients with acute coronary syndromes","volume":"335","author":"Antman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib33","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/jama.286.19.2405","article-title":"Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction. Results from a randomized trial","volume":"286","author":"Morrow","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib34","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJMoa011053","article-title":"The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes","volume":"345","author":"de Lemos","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib35","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.CIR.0000015464.18023.0A","article-title":"Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide","volume":"105","author":"Sabatine","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib36","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome P-450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib37","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1001\/jama.2011.1703","article-title":"Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease","volume":"306","author":"Mega","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib38","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ahj.2008.07.023","article-title":"Design and rationale of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe\/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes","volume":"156","author":"Cannon","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib39","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ahj.2010.06.042","volume":"160","author":"Ruff","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib40","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ahj.2011.07.018","article-title":"Study design and rationale for the Stabliization of pLaques usIng Darapladib\u2013Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome","volume":"162","author":"O'Donoghue","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib41","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ahj.2011.08.006","article-title":"The design and rationale of the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus\u2013Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 study","volume":"162","author":"Scirica","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jtcvs.2012.07.001_bib42","first-page":"385","article-title":"Design and rationale of the LAPLACE-TIMI 57 trial: a phase II, double-blind, placebo-controlled study of the efficacy and tolerability of a monoclonal antibody inhibitor of PCSK9 in subjects with hypercholesterolemia on background statin therapy","volume":"35","author":"Kohli","year":"2012","journal-title":"Clin\u00a0Cardiol"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522312007854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522312007854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:50:20Z","timestamp":1758387020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522312007854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0022522312007854"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2012.07.001","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Thrombolysis in Myocardial Infarction (TIMI) Study Group experience","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2012.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}